Actively Recruiting

Phase Not Applicable
Age: 18Years - 110Years
All Genders
ID06743295

Evaluation of Artificial Intelligence Based Noise Reduction in Phonak Hearing Aid on Patients With Hearing Impairment and Cochlear Implants

Led by Mayo Clinic · Updated on 2026-02-06

500

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are evaluating if an artificial intelligence (AI)-based noise reduction feature in Phonak hearing aids can improve hearing and speech perception for people with hearing loss. The study focuses on patients with hearing impairment, including those with cochlear implants on one side using a hearing aid on the opposite ear. The goal is to find out whether this AI technology offers measurable benefits in different listening environments. Participants with hearing loss will receive the Phonak Audéo Sphere Infinio hearing aid equipped with DEEPSONIC™ Deep Sound Optimized Neural Integrated Chip, which uses deep neural networks to reduce background noise. Speech will be played at a comfortable volume in quiet, moderate noise, and high noise settings. The study will compare speech perception scores using different hearing aid program settings: quiet, moderate noise, and advanced AI-based noise reduction for high noise. During the study, participants will undergo single-word and sentence testing at baseline to assess their speech perception. Tests will be conducted in various noise environments to evaluate how well the AI noise reduction improves hearing. The study will monitor participants' hearing performance with and without the AI noise reduction feature. The total participation duration and follow-up details are not specified.

CONDITIONS

Brief Title

AI Noise Reduction in Phonak Hearing Aids

Who Can Participate

Age: 18Years - 110Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients with hearing impairment not using hearing aids
  • Individuals with hearing impairment currently using hearing aids
  • Cochlear implant patients with a single-sided implant using a hearing aid in the opposite ear
Not Eligible

You will not qualify if you...

History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Implementation

Duration - Duration of the intervention as per study protocol

Participants with hearing loss will be fitted with the Phonak Audéo Sphere™ Infinio (PAI) hearing aid featuring AI-based noise reduction technology.

Visits for testing speech perception in quiet, moderate, and high noise environments

Trial Site Locations

Total: 1 location

1

Mayo Clinic in Rochester

Rochester, Minnesota, United States, 55905

Actively Recruiting

Loading map...

Research Team

C

Clinical Research Study Coordinator

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NON_RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Similar Trials

A Comparative Analysis of Speech Perception Between Cochlear...

Hearing Loss

Actively Recruiting

6 locations

A Double-Blinded, Placebo-Controlled, Randomized Phase 1/2a ...

Central Auditory Processing Disorder

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here